Skip to content
  • Sunday, 26 July 2026
  • 4:34 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Washington University Researchers Develop High Efficiency Platinum Free Catalyst for Green Hydrogen Production
Advanced Materials Science

Washington University Researchers Develop High Efficiency Platinum Free Catalyst for Green Hydrogen Production

Nila Kartika Wati Jun 1, 2026 0

In a significant advancement for the global transition toward sustainable energy, researchers at the McKelvey School of Engineering at Washington…

Read More
Advanced Materials Science

Washington University Researchers Pioneer Low Cost Platinum Free Catalyst for Efficient Green Hydrogen Production

Nila Kartika Wati May 25, 2026 0

In an era defined by the urgent need to decarbonize global industrial sectors, researchers at Washington University in St. Louis…

Read More
Pharmaceutical R&D

European Commission Approves Keytruda Combination Therapy for PD-L1-Positive Platinum-Resistant Ovarian Cancer

Teuku Ryan Apr 6, 2026 0

The European Commission (EC) has granted approval for Keytruda (pembrolizumab) in combination with paclitaxel, with or without bevacizumab, as a…

Read More
Science News: A Century of Empowering Public Understanding of ScienceStanford Researchers Pioneer Non-Invasive Ultrasound Technology to Generate Therapeutic Light Within Deep Body TissuesMicroplastic Ingestion and Inhalation Linked to the Acceleration of Neurodegenerative Disorders Through Multiple Biological PathwaysCornell University Researchers Develop Grain of Salt Sized Neural Implant for Long Term Wireless Brain Monitoring
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ